Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Kolz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|August 31, 2006
Dose selection and population pharmacokinetics of PEG-Intron in patients with chronic myelogenous leukaemiaSamir Gupta, Juif Jen, Karen Kolz, et al.
European Journal of Clinical Pharmacology|December 17, 2010
Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis CSamir K Gupta, Karen Kolz, David L Cutler
Bioanalysis|March 23, 2011
Biotherapeutic bioanalysis: a multi-indication case study reviewHeather A Myler, Allison Given, Karen Kolz, et al.
Journal of Clinical Pharmacology|April 3, 2007
The effect of multiple doses of peginterferon alfa-2b on the steady-state pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapySamir K Gupta, Edward Sellers, Eugene Somoza, et al.
British Journal of Clinical Pharmacology|June 9, 2007
Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiencySamir K Gupta, Suzanne K Swan, Thomas Marbury, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|August 31, 2006
Dose selection and population pharmacokinetics of PEG-Intron in patients with chronic myelogenous leukaemiaSamir Gupta, Juif Jen, Karen Kolz, et al.
European Journal of Clinical Pharmacology|December 17, 2010
Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis CSamir K Gupta, Karen Kolz, David L Cutler
Bioanalysis|March 23, 2011
Biotherapeutic bioanalysis: a multi-indication case study reviewHeather A Myler, Allison Given, Karen Kolz, et al.
Journal of Clinical Pharmacology|April 3, 2007
The effect of multiple doses of peginterferon alfa-2b on the steady-state pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapySamir K Gupta, Edward Sellers, Eugene Somoza, et al.
British Journal of Clinical Pharmacology|June 9, 2007
Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiencySamir K Gupta, Suzanne K Swan, Thomas Marbury, et al.
Pageof 1